Vanguard Group Inc Standard Biotools Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 17,225,250 shares of LAB stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,225,250
Previous 17,156,146 0.4%
Holding current value
$18.4 Million
Previous $30 Million 38.04%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$1.01 - $2.06 $69,795 - $142,354
69,104 Added 0.4%
17,225,250 $18.6 Million
Q4 2024

Feb 11, 2025
SELL
$1.5 - $2.26 $203,919 - $307,237
-135,946 Reduced 0.79%
17,156,146 $30 Million
Q3 2024

Nov 13, 2024
BUY
$1.42 - $2.35 $1.83 Million - $3.03 Million
1,288,934 Added 8.05%
17,292,092 $33.4 Million
Q2 2024

Aug 13, 2024
BUY
$1.65 - $2.92 $4.9 Million - $8.67 Million
2,969,115 Added 22.78%
16,003,158 $28.3 Million
Q1 2024

May 10, 2024
BUY
$1.87 - $2.78 $16.6 Million - $24.7 Million
8,900,104 Added 215.29%
13,034,043 $35.3 Million
Q4 2023

Feb 14, 2024
BUY
$1.59 - $2.73 $253,466 - $435,197
159,413 Added 4.01%
4,133,939 $9.14 Million
Q3 2023

Nov 14, 2023
BUY
$1.9 - $3.05 $60,108 - $96,489
31,636 Added 0.8%
3,974,526 $11.5 Million
Q2 2023

Aug 14, 2023
SELL
$1.47 - $2.56 $19,224 - $33,479
-13,078 Reduced 0.33%
3,942,890 $7.61 Million
Q4 2022

Feb 10, 2023
BUY
$0.93 - $1.52 $1,501 - $2,453
1,614 Added 0.04%
3,955,968 $4.63 Million
Q3 2022

Nov 14, 2022
BUY
$1.1 - $2.06 $436,480 - $817,408
396,800 Added 11.15%
3,954,354 $4.35 Million
Q2 2022

Aug 12, 2022
SELL
$1.6 - $3.99 $574,844 - $1.43 Million
-359,278 Reduced 9.17%
3,557,554 $5.69 Million
Q1 2022

May 13, 2022
BUY
$2.8 - $3.96 $137,650 - $194,677
49,161 Added 1.27%
3,916,832 $14.1 Million
Q4 2021

Feb 14, 2022
BUY
$3.63 - $6.13 $1.02 Million - $1.72 Million
280,792 Added 7.83%
3,867,671 $15.2 Million
Q3 2021

Nov 12, 2021
SELL
$5.5 - $7.41 $423,313 - $570,318
-76,966 Reduced 2.1%
3,586,879 $23.6 Million
Q2 2021

Aug 13, 2021
BUY
$4.35 - $6.35 $15.9 Million - $23.3 Million
3,663,845 New
3,663,845 $22.6 Million

Others Institutions Holding LAB

# of Institutions
151
Shares Held
280M
Call Options Held
6K
Put Options Held
36.6K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $84.2M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email